In August 2026, CITEST Diagnostics Inc. has officially rolled out its Paroxetine (PRT) Rapid Tests, a professional-grade in-vitro diagnostic device created to spot paroxetine inside human urine specimens. Built around the competitive?binding principle, the test relies on capillary upward?flow of urine to compete against fixed paroxetine protein conjugates. It aids medical practitioners in monitoring patients' medication, taking compliance and stopping drug misuse. Clear cut test findings can be obtained within 5 minutes, and no complicated lab-equipment is required.

Designed for hassle-free professional medication-monitoring tasks, the Paroxetine (PRT) Rapid Tests come with multiple prominent merits. It delivers high accuracy detection. Three available styles, cassette, dipstick and panel, meet diverse testing demands. Reliable outcomes show up in five minutes. The operation is simple and results can be distinguished visually. Besides, the test is capable of resisting disturbance caused by urine pH value and specific gravity.

Intended for trustworthy paroxetine medication surveillance, this rapid-testing series collects urine as the specimen and only calls for basic operating skills from laboratory staff. Its three formats carry separate catalogue numbers. The cassette format test (Cat. No.: RTPRTCI) is packed as 25 test kits (25T). The panel format product (Cat. No.: RTPRTACI) has 25T and 40T packaging choices. The dipstick version (Cat. No.: RTPRTBCI) is supplied in 50T packs. Every product is meant solely for professional in-vitro diagnostic use.

Paroxetine ranks as the most powerful SSRI antidepressant for mood related disorders. Around 95% of the substance attaches to plasma protein, and most paroxetine gets discharged in urine following liver metabolism. The cut-off concentration of this rapid test series is set to 1,000 ng/mL. With stable anti-interference performance, these detection products suit hospitals, detoxification centres as well as clinical laboratories across the world.

The Paroxetine (PRT) Rapid Tests respond to the clinical demand of simple urine-screening for antidepressant medication tracking. With multi format selections, interference resistance and speedy result reading, this newly-issued test lineup strengthens CITEST Diagnostics Inc.'s standing as a dependable supplier of rapid diagnostic goods, focusing on steady performance to help medical related facilities check patients' medication-taking adherence.